Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentazocine vs Lorazepam for Manic Symptoms
NCT00431184Phase 2Completed
- Sponsor
- McLean Hospital
- Start
- Jan 2007
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pentazocine in bipolar disorder (BD) and schizoaffective disorder (2 arms), sponsored by McLean Hospital. Primary endpoint: Mania Acute Rating Scale at Day 2. Started Jan 2007; status: completed.
02
Drugs
pentazocine
03
Conditions
bipolar disorder (BD)schizoaffective disorder
Beyond the preview
Go deeper on NCT00431184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00431184.